Hep Fall 2015 – Special Issue
Hep Fall 2015 – Special Issue
In this issue, you’ll meet yoga enthusiast Sheila Dewey. Scroll down to click on her story and to see what else is inside.
Also Available On:
Feature
Journey to a Cure
How to get and stay healthy before, during and after treatment
From the Editor
I Feel Good
Getting and staying healthy before, during and after HCV treatment is vital for your wellness.
Treatment News
Technivie Approved for Genotype 4
The U.S. Food and Drug Administration (FDA) recently approved AbbVie’s single-tablet combination regimen Technivie plus ribavirin to treat gen...
Daklinza Approved for Genotype 3
The U.S. Food and Drug Administration has approved the combination of Bristol-Myers Squibb’s NS5A inhibitor Daklinza with Gilead Sciences’ Sov...
Excellent Cure Rates Achieved in Difficult-to-Treat Cases
Studies of Gilead Sciences’ Harvoni and AbbVie’s Viekira Pak have boasted excellent cure rates among people with genotype 1 of hep C and cirrh...
Injection Drug Use Fuels Outbreaks
The CDC has issued an alert to public health departments and clinicians nationwide to be vigilant for HIV outbreaks similar to one that has st...
The Race Is On to Shorten Length of Treatment
With about half of people with genotype 1 able to take just eight weeks of Harvoni, the race is on to best this treatment length or offer it t...
